Mesoblast | MSB - Operating Profit


Mesoblast reported $-20M in Operating Profit for its fiscal semester ending in June of 2026.





Operating Profit Change Date
Avita Medical AUD -6.86M 3.55M Jun/2026
Clinuvel Pharmaceuticals AUD 13.51M 15.95M Dec/2025
Cochlear AUD 261.1M 135.55M Dec/2025
CSL USD 2.64B 1.97B Dec/2025
Pacific Edge NZD -16.94M 2.46M Jun/2026
PYC Therapeutics AUD -22.59M 9.12M Dec/2025
Ramsay Health Care AUD 541.1M 3.9M Dec/2025
Sonic Healthcare AUD 435.76M 193.66M Dec/2024
Starpharma Holdings AUD -873K 1.43M Dec/2025
Telix Pharmaceuticals AUD 46.36M 38.32M Jun/2026